Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
Osteoprotegerin inhibits the d...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
書目詳細資料
Main Authors:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
格式:
Journal article
出版:
2001
持有資料
實物特徵
Other Versions (1)
相似書籍
職員瀏覽
相似書籍
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
由: Croucher, P, et al.
出版: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
由: Croucher, P, et al.
出版: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
由: Croucher, P, et al.
出版: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
由: Croucher, P, et al.
出版: (2001)
Osteoprotegerin and the development of myeloma bone disease
由: Croucher, P, et al.
出版: (2004)